Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) — Net Asset Momentum
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) recorded a net asset momentum of 3.4% as of December 2023, with net assets of TL231.70 Million TRY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Oncosem Onkolojik Sistemler Sanayi ve Ti book value and equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Net Asset Momentum (2020–2023)
This chart tracks Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s year-over-year net asset growth across 4 annual reporting periods from 2020 to 2023. The most recent momentum reading is +3.4%, with net assets of TL231.70 Million TRY as of December 2023. For live market cap and overall valuation, see market value of Oncosem Onkolojik Sistemler Sanayi ve Ti.
Annual Net Asset History for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2023)
The table below shows the complete annual net asset history for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. from 2020 to 2023, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check ONCSM tangible net worth ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (TRY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2023 | TL231.70 Million | TL338.31 Million | TL106.61 Million | ▲ +3.4% |
| 2022 | TL224.08 Million | TL349.58 Million | TL125.50 Million | ▲ +184.4% |
| 2021 | TL78.80 Million | TL129.55 Million | TL50.75 Million | ▲ +3.7% |
| 2020 | TL76.02 Million | TL132.13 Million | TL56.11 Million | — |